Dear reader,
This issue of Human Vaccines & Immunotherapeutics starts with seven articles on Influenza, including a review on egg- and cell culture-produced quadrivalent vaccines (Perez-Rubio, p 1746), a safety report on the seasonal vaccine Fluarix Tetra in England (de Lusignan, p 1762), a study of vaccine uptake among the Italian elderly (Marano, p 1772), analysis of gene expression in PBMCs from vaccinated children (Alcorn, p 1782), a Phase 2 safety and immunogenicity trial of trivalent inactivated vaccine in older adults (Sarsenbayeva, p 1791), and a Commentary on public acceptance of a future universal vaccine (Quinn, p 1798).
The HPV section presents research articles on the effect of delayed vaccine dosing on antibody avidity (Brady, p 1802), vaccine attitudes among Japanese doctors (Nagase, p 1808) and U.S. primary-care workers and parents (Dang, p 1814), vaccine-promoting campaign on Facebook in Brazil (Pereira da Veiga, p 1824), and a commentary on the equity and ethics of adolescent vaccination (Sundaram, p 1835).
Six articles on Licensed Vaccines include a review on the multifold use of the BCG vaccine (Yamazaki-Nakashimada, p 1841), an assessment of varicella vaccine in an outbreak setting and impact on breakthrough varicella (Qin, p 1851), a novel assay for quantification of glycoprotein in rabies vaccines (Gairola, p 1857), analysis of potency of Sabin inactivated poliovirus vaccine after freezing (Cai, p 1866), a Phase 4 study of adverse events following MMRV vaccine in Italy (Stefanizzi, p 1875), and a commentary on improving childhood vaccination rates (Clark, p 1884).
The Immunotherapy segment features a commentary on targeting the β-adrenergic signaling pathway for improved cancer immunotherapy (Inderberg, p 1888) and a report on Treg regulation via a tryptophan metabolite in asthma immunotherapy (Hu, p 1891).
Three Public Health articles include a commentary on the broadest benefits and implications of routine vaccination (Nandi, p 1900), a survey of childhood vaccine preferences among Chinese parents (Huang, p 1905), and a pilot study of a mobile app for monitoring stock of vaccines in primary healthcare facilities in South Africa (Iwu, p 1911).
Three research articles on Pneumococcal vaccines investigate the impact of PCV on carriage in HIV-positive children (Khan, p 1918), indirect costs of disease in Turkish adults (Sevilla, p 1923), and cost-effectiveness of sequential and single-dose vaccinations of adults in Hong Kong (Shami, p 1937).
The Meningococcal section comprises an assessment of serogroup B disease burden in Brazil (Chicuto, p 1945) and a Letter to the Editor reporting a case of a Syrian refugee with meningococcal empyema (Akyol, p 1951).
Two studies on Rotavirus look at a possible link between vaccine and food allergy (Karakaş, p 1952), and preclinical characterization of a trivalent subunit vaccine (Lakatos, p 1957).
Finally we are happy to present a review of vaccine Acceptance among pregnant women (Rosso, p 1969), a commentary on ethical decision-making in biopharmaceutical Development (Poplazarova, p 1981), a Technology article on TLR7 agonist as influenza vaccine adjuvant (Kaushik, p 1989), and a clinical study on IgM-based Passive Vaccination approach as adjuvant treatment for serious infectious disease in pediatric intensive care unit (Abdullayev, p 1997).
Our monthly News, Policy and Profiles (NP&P) track offers a selection of the latest news in the field of vaccines and immunotherapeutics. In this section we also regularly publish opinion pieces on timely, interesting and controversial topics related to vaccines and immunotherapeutics, profiles of companies and organizations, as well as portraits of distinguished scientists in our field. Please contact Acquisitions Editor Adam Weiss ([email protected]) with your ideas for commentaries, opinion pieces, profiles and portraits. Your suggestions for and contributions to our N&P&P track are always welcome!
Sincerely,
Ronald Ellis, PhD
Editor-in-Chief
Adam Weiss, PhD
Acquisitions Editor